Skip to main content

Table 2 Biochemical test results at the baseline and during the follow-up

From: Effects, safety, and plasma levels of topiroxostat and its metabolites in patients receiving hemodialysis

Parameter

Baseline

Week 4

Week 12

Week 26

Week 52

Number of participants

20

20

19

19

19

BUN (mmol/L)

25.1 ± 5.2

24.3 ± 5.4

20.8 ± 6.9*

20.8 ± 4.9*

23.5 ± 5.2

Creatinine (μmol/L)

1105.4 ± 244.4

1079.2 ± 210.6

1003.8 ± 286.9

1030.2 ± 281.2*

1018.7 ± 251.8*

Total protein (g/L)

63.2 ± 5.0

64.7 ± 5.4

61.3 ± 4.9

62.4 ± 7.0

63.2 ± 5.4

Albumin (g/L)

37.6 ± 3.1

37.3 ± 4.6

35.8 ± 4.6

36.7 ± 5.3

36.1 ± 3.9

AST (IU/L)

12.6 ± 7.3

11.4 ± 5.2

10.5 ± 4.4

12.1 ± 5.9

11.5 ± 5.3

ALT (IU/L)

10.8 ± 6.3

9.8 ± 4.0

9.2 ± 3.5

10.5 ± 3.0

9.7 ± 5.6

ALP (IU/L)

243.8 ± 94.8

218.9 ± 69.7

213.6 ± 92.4

243.1 ± 133.3

224.9 ± 78.7

Total bilirubin (μmol/L)

4.4 ± 1.5

4.5 ± 1.7

4.4 ± 1.8

4.8 ± 2.3

4.5 ± 1.3

LDH (IU/L)

186.6 ± 25.5

185.0 ± 29.1

184.1 ± 31.9

191.8 ± 40.0

181.7 ± 27.1

Total cholesterol (mmol/L)

4.273 ± 0.710

4.439 ± 0.900

4.266 ± 0.797

4.539 ± 0.918

4.241 ± 1.159

Triglycerides (mmol/L)

1.214 ± 0.414

1.096 ± 0.281

1.036 ± 0.333

1.149 ± 0.386

1.213 ± 0.635

HDL cholesterol (mmol/L)

1.24 ± 0.39

1.38 ± 0.49

1.41 ± 0.52

1.52 ± 0.72

1.30 ± 0.44

LDL cholesterol (mmol/L)

2.41 ± 0.41

2.56 ± 0.66

2.45 ± 0.63

2.53 ± 0.74

2.44 ± 0.89

  1. BUN blood urea nitrogen, AST aspartate aminotransferase, ALT alanine aminotransferase, ALP alkaline phosphatase, LDH lactate dehydrogenase
  2. *p < 0.05 (paired t test vs. baseline, after Bonferroni corrections). Mean ± SD